As part of its new strategic focus, Wellcome aims to develop new and improved early interventions for anxiety, depression and psychosis, in ways that reflect the priorities and needs of people experiencing these conditions. This work involves advancing scientific understanding of how brain, body and environment interact in the trajectory of these problems; and finding new and usable ways to predict, identify and intervene as early as possible.
Disturbances in sleep and circadian rhythms can predict the onset and relapse of mental disorder, are common in cases of depression, anxiety, bipolar disorder and schizophrenia, and have a major bearing on quality of life. Greater severity of insomnia and/or circadian disruption is associated with higher levels of psychopathology and suicidality, increased risk of relapse, and poorer treatment outcomes.
You can apply to this call if you are a team:
- from relevant disciplines from eligible organisations
- based anywhere in the world, apart from mainland China and sanctioned territories
Closing date: 19 October 2022